Business Development Manager, TOS
Boost your chances before you apply.
Champions Oncology Inc.
Summary
The Business Development Manager is responsible for identifying and developing new opportunities within the Translational Oncology Solutions offering in Asia. They will manage the full sales cycle, cultivate client relationships, and collaborate with internal R&D and operations teams to win studies.
Job Description
Job Details: Level: Experienced, Job Location: South Korea - TBD, South Korea, Position Type: Full Time, Education Level: PhD, Salary Range: Undisclosed, Travel Percentage: 25% to 50%, Job Shift: Monday - Friday, 9:00 AM - 5:00 PM, Job Category: Business Development,
TITLE AND CLASSIFICATION: Business Development Manager, Translational Oncology Solutions
REPORTING LOCATION: South Korea, Remote*WE ARE SEEKING A CANDIDATE LIVING IN SOUTH KOREA*
REPORTING MANAGER Head of Business Development, Asia
PRIMARY OBJECTIVES: The Business Development Associate/Manager is a fast-paced, competitive role, responsible for identifying and developing new opportunities within our Translational Oncology Solutions offering. The BD Associate/Manager will work closely with commercial, marketing, R&D and operation teams to lead business development efforts in Asia. The ideal candidate will have a firm understanding of oncology research and market dynamics. The candidate will also possess a strong ability to carry out scientific discussions with senior researchers within biopharma and discuss the use of research services provided by Champions Oncology. The successful candidate will be a self-motivated and driven individual who is goal-oriented, methodical, tenacious, and can effectively interact with a team at all levels.
DUTIES AND RESPONSIBILITIES
Executes business development initiatives and achieves annual sales targets for territory.
Identifies key prospective clients and perform strategic, scientific, tailored outreach to increase new business and expand existing accounts within designated territory.
Provides appropriate guidance to client to align Champions products and solutions to their needs
Independently qualifies, prioritizes and manages opportunities throughout sale cycle
Establishes and cultivates client relationships by maintaining frequent contact and responding to client requests in a timely and detailed fashion.
Generates and manages statement of works for designated territory from drafting to approval.
Provides weekly sales activity reports.
Leverages Champions' capabilities and differentiation frameworks to provide unique solutions to partners
Collaborates with companywide personnel to achieve superior customer satisfaction.
Organizes, prepare, and hosts client meetings.
Leads client presentations based on specific client needs
Uses CRM to manage internal communication and maintain detailed documentation for each account and sales opportunity within territory.
Responsible for opportunity management and accurate pipeline forecasting.
Collaborates effectively with Medical Affairs, R&D, project leadership and operation teams at Champions Oncology to bring potential opportunities to their attention and to identify and win studies.
Stays abreast of scientific development in oncology and IO, as well as internal product development.
Qualifications: KNOWLEDGE, SKILLS, AND ABILITIES
Relevant experience in the biopharma industry with comprehensive understanding of drug discovery and development and a broad knowledge of the biopharma and healthcare sector.
At least 3-5 years relevant experience working in and a deep knowledge of the oncology and immuno-oncology therapeutic area.
Business development or related experience and an established network in the biopharmaceutical industry preferred
Solid understanding of drug development process and pre-clinical research.
Passion for improving patient lives.
Strong interpersonal, analytical, critical-thinking, verbal and written communication skills.
Highly developed organizational skills, operational skills, and ability to understand the content of and memorialize interactions of potential partners.
Self-motivated, attention to detail, and proven ability to work well on teams.
Exceptional recent PhD graduates or Postdoctoral researchers who demonstrate strong scientific expertise, commercial aptitude, and the potential to develop into a business development role may also be considered. Candidates who do not meet the Manager-level experience requirements may be considered for a Business Development Associate position.
EDUCATION AND EXPERIENCE
Doctorate in Biochemistry, Molecular Biology, or related field.
Advanced industry knowledge
Ability to manage difficult client and/or financial situations
Ability to differentiate Champions from competitors
Demonstrated ability to acquire and grow client base
PHYSICAL DEMANDS AND WORK ENVIRONMENT (for office-setting personnel)
Must be able to sit for long periods of time using a computer in a typical office environment in a remote/home office setting
Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios.
From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.
At the core of our services is the Champions TumorGraft® (CTG) platform, a comprehensive, unique compendium of PDX models that preserve the biological characteristics of human tumors and are highly predictive of clinical outcomes. Services utilizing Champions TumorGrafts® PDX tumor models include evaluating tumor sensitivity/resistance to various single, combination, standard and novel chemotherapy agents, biomarker discovery and the identification of novel drug combinations.
Champions TumorGraft® PDX models are procured through agreements our Clinical Collaboration Network, a series of renowned oncology institutions in the US and around the world, as well as through the company’s Personalized Oncology Solutions business.
Personalized Oncology Solutions assist clinical oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients’ cancer tissues, as appropriate. Additionally, the company offers personalized PDX development, drug studies and genome sequencing, whereby physicians evaluate the effects of cancer drugs and understand the genetic makeup of each patient’s tumor, enabling them to better select treatment regimens.
Founded
2007
Company size
201-500 employees
Industry
Biotechnology
Org type
Public Company
Headquarters
Hackensack, New Jersey
Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios.
From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.
At the core of our services is the Champions TumorGraft® (CTG) platform, a comprehensive, unique compendium of PDX models that preserve the biological characteristics of human tumors and are highly predictive of clinical outcomes. Services utilizing Champions TumorGrafts® PDX tumor models include evaluating tumor sensitivity/resistance to various single, combination, standard and novel chemotherapy agents, biomarker discovery and the identification of novel drug combinations.
Champions TumorGraft® PDX models are procured through agreements our Clinical Collaboration Network, a series of renowned oncology institutions in the US and around the world, as well as through the company’s Personalized Oncology Solutions business.
Personalized Oncology Solutions assist clinical oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients’ cancer tissues, as appropriate. Additionally, the company offers personalized PDX development, drug studies and genome sequencing, whereby physicians evaluate the effects of cancer drugs and understand the genetic makeup of each patient’s tumor, enabling them to better select treatment regimens.
Founded
2007
Company size
201-500 employees
Industry
Biotechnology
Org type
Public Company
Headquarters
Hackensack, New Jersey